جدول الترويج Perspective Therapeutics, Inc.
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. مزيد من التفاصيل| IPO date | 2005-11-10 |
|---|---|
| ISIN | US46489V1044 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.perspectivetherapeutics.com |
| Цена ао | 2.62 |
| تغير السعر يوميا: | -1.15% (2.62) |
|---|---|
| تغير السعر في الأسبوع: | -0.7663% (2.61) |
| تغير السعر شهريا: | -14.52% (3.03) |
| تغير السعر خلال 3 أشهر: | -25.57% (3.48) |
| تغير السعر على مدى ستة أشهر: | -80.26% (13.12) |
| تغير السعر سنويا: | +142.06% (1.07) |
| تغير السعر على مدى 3 سنوات: | +640% (0.35) |
| تغير السعر على مدى 5 سنوات: | +181.52% (0.92) |
| تغير الأسعار منذ بداية العام: | -15.64% (3.07) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| Vanguard Group Inc | 13213750 | 2.25 |
| Baker Brothers Advisors, LLC | 7639703 | 1.3 |
| Blackrock Inc. | 4538389 | 0.77 |
| Geode Capital Management, LLC | 2516649 | 0.43 |
| Ghost Tree Capital, LLC | 1600000 | 0.27 |
| Osterweis Capital Management, Inc. | 1582100 | 0.27 |
| HighTower Advisors, LLC | 1332238 | 0.23 |
| Perkins Capital Management, Inc. | 700000 | 0.12 |
| State Street Corporation | 671524 | 0.11 |
| Taylor & Morgan Wealth Management, LLC | 625000 | 0.11 |
| ETF | يشارك, % | الربحية لهذا العام, % | توزيعات الأرباح, % |
|---|---|---|---|
iShares Russell 2000 Growth ETF
|
0.04295 | 38.04 | 0.6026 |
| iShares Morningstar Small-Cap Growth ETF | 0.02697 | 33.63 | 0.72598 |
| iShares Morningstar Small-Cap Growth ETF | 0.02697 | 587.89 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.01351 | 30.1 | 1.60498 |
| iShares Morningstar Small-Cap ETF | 0.01351 | 391.25 | 1.60498 |
| iShares Russell 3000 ETF | 0.00132 | 24.83 | 1.43482 |
| 0.02 | 184.29 | 1.11 |
| مشرف | مسمى وظيفي | قسط | سنة الميلاد |
|---|---|---|---|
| Mr. Johan M. Spoor | CEO & Director | 855.78k | 1972 (53 سنة) |
| Mr. Jonathan R. Hunt | CFO and Principal Financial & Accounting Officer | 944.35k | 1967 (58 سنين) |
| Mr. Shane Cobb | Executive Vice President of Operations | N/A | |
| Dr. Michael K. Schultz Ph.D. | Chief Science Officer | N/A | |
| Mr. Andrew Bright | Executive Vice President of Brachytherapy | N/A | |
| Dr. Markus Puhlmann M.B.A., M.D. | Chief Medical Officer | 633.14k | 1966 (59 سنين) |
| Mr. Amos Hedt BA, PGradDip | Chief Business Strategy Officer | N/A | |
| Dr. Frances L. Johnson M.D. | Chief Innovation Officer | N/A | |
| Mr. David Hauser Ph.D. | Senior Vice President of Clinical Operations | N/A | |
| Steve Keefe | Senior Vice President of Clinical Development |
عنوان: United States, Richland. WA, 350 Hills Street - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://www.perspectivetherapeutics.com
موقع إلكتروني: https://www.perspectivetherapeutics.com
